What is the specialty of Dr. Dinesh Bhurani?

Dr. Dinesh Bhurani specialty is Hematologist

What is the experience of Dr. Dinesh Bhurani?

Dr. Dinesh Bhurani is Hematologist with 16 years of experience.

What does a Hematologist do?

A hematologist deals with the treatment of blood disorders and malignancies, including different types of hemophilia, leukemia, lymphoma, anemia etc.

What are the typical symptoms of a blood related disorder?

Typical symptoms include fatigue, shortness of breath, Trouble concentrating from lack of oxygenated blood in the brain, Muscle weakness, Fast heartbeat etc.

Which tests/ investigations are generally required by the Hematologist?

The investigations include Full Blood Count Testing, White Blood Cells (WBC) Testing, Red Blood Cells (RBC) Testing, Hemoglobin Testing, Hematocrit and Platelets, Mono Screening, Vitamin B12 Deficiency Testing, and Renal Profiling.

Can a hematologist diagnose cancer?

Hematologic tests aid in the diagnosis of blood diseases such as anemia, certain cancers of the blood and inflammatory diseases, and also help monitor blood loss and infection.

Can blood cancers be cured?

Most of them are curable as it all depends upon the type of blood cancer the patient is suffering from.

Dr. Dinesh Bhurani, Hematologist in New Delhi, India - Appointment

About Dr. Dinesh Bhurani

Dr. Dinesh Bhurani is a hematologist-oncologist with 16+ years of experience.
His recognition includes Award Paper for "Comparison of various variables including foot length with gestational age" by Indian Academy of Pediatrics, state branch in 1997.
Dr. Bhurani has completed his MBBS from JIWAJI University, MD from Pt Ravishankar Shukla University, Raipur and DM from Christian Medical College & Hospital, Vellore.
He is active member of Indian Society of Hematology and Blood Transfusion, Pediatric Hematology - Oncology Chapter of Indian Academy of Pediatrics and The Royal College of Pathologists of Australia (RCPA).

Hospital

Location

New Delhi, India

Special Interest

Blood Transfusion, Bone Marrow Transplant, Chelation Therapy, Lymphatic drainage, Thalassaemia, Haemophilia, Biochemistry

List Of Treatments

Bone Marrow Transplant

Book Appointment Contact Doctor

Work Experience of Dr. Dinesh Bhurani

Associate Consultant, Sir Ganga Ram Hospital, New Delhi

Consultant, CMC, Vellore

Director, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi

Director, Max Super Speciality hospital, Shalimar Bagh, New Delhi

Director, BLK Super Speciality Hospital, New Delhi

Dr. Dinesh Bhurani's

DM, 2001, Christian Medical College & Hospital, Vellore

MD, 1997, Pt Ravishankar Shukla University, Raipur

MBBS, 1993, JIWAJI University, Gwalior

Award Paper: "Comparison of various variables including foot length with gestational age". Indian Academy of Pediatrics, state branch in 1997

Folinic acid administration following MTX as prophylaxis for GVHD in allogeneic HSCT centres in Australia and New Zealand. Bhurani D, Schifter M, Kerridge I. Bone Marrow Transplant. 2008 Oct; 42(8):547-50. PMID: 18622418.
The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S. Haematologica. 2006 Jul; 91(7):972-5. PMID:16818287.
Successful surgical hemostasis in patients with von Willebrand disease following infusion of KoateDVI. Srivastava A, Mathews V, Bhurani D, Baidya S, Chandy M. Thromb Haemost. 2002 Mar; 87(3):541-3. PMID:11916092.
Treatment of myelodysplastic syndrome transforming into acute myelogenous leukemia with azacytidine: a retrospective study from cancer centre in northern India. Suresh P, Sharma A, Bhurani D. Indian J Hematol Blood Transfus. 2010; 26 (3):114. PMID:21886398.
Role of steroids in Myelodysplastic Syndrome. Dinesh Bhurani, Alok Shrivastava, Mamman Chandy. Indian Journal Haematology and Blood Transfusion. [Abstract]
Flow cytometric immunophenotypic analysis of multiple myeloma. Bhurani D, Chapple P, Wei A, Juneja S. Abstract. Combined Annual Scientific Meeting of HSANZ, ANZSBT and ASTH. 2004
Is dual expression of CD9/cytCD68 a useful marker of Minimal Residual Disease (MRD) in Acute Promyelocytic Leukaemia (APL). Bhurani D, Smith C, Thurlow P, Duggan J, Came N. Abstract. Combined Annual Scientific Meeting of HSANZ, ANZSBT and ASTH. 2004.
Comparison of various variables including foot length with gestational age. Award paper in Indian Academy of Pediatrics, state branch. 1997.